Upregulation of TRPM3 Expression Promotes the Autophagy in Ovarian Cancer Cells via Regulating Beclin1 Expression

Ru ZHANG,Jing SUN,Li-xia CHEN,Xiao-wei XI,You-ji FENG,Yun-yan SUN

DOI: https://doi.org/10.13241/j.cnki.pmb.2018.12.002

2018-01-01

Abstract:Objective: To explore the expression of transient receptor potential melastatin 3 (TRPM3) and Beclin1 in ovarian cancer and their effect on the autophagy of ovarian cancer cells. Methods: 6 cases of normal ovarian tissues and 20 cases of ovarian cancer tissues were collected to detect the expression of TRPM3 and Beclin1 via immunohistochemical method. Western blotting assay was used to detect the expression of TRPM3 and Beclin1 in a human normal ovarian epithelial cell line Moody and ovarian cancer cell lines Hey, ES-2. Hey and ES-2 were transfected with TRPM3-siRNA, and western blotting assay was used to detect the silencing of TRPM3 and expression changes of Beclin1, LC3 and p62. Results: In normal ovarian tissues and ovarian cancer tissues, the positive expression rates of TRPM3 were 33.3％ and 80.0％, respectively (P＜0.05), while the positive expression rates of Beclin1 were 33.3％ and 60.0％, respectively (P＞0.05). Compared with the normal ovarian epithelial cells Moody, TRPM3 and Beclin1 protein expression levels in the ovarian cancer cells Hey and ES-2 were significantly higher(P＜0.05). The expression of Beclin1 and LC3 were downregulated, while p62 was upregulated significantly when the expression of TRPM3 in ovarian cancer cell lines were silenced (P＜0.05). Conclusions: TRPM3 were highly expressed in ovarian cancer tissues and cells, while TRPM3 may promote the autophagy in ovarian cancer cells by regulating Beclin1.